These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum calcium, phosphate and alkaline phosphatase and morphometric bone examinations in 30 patients with renal insufficiency. Duursma SA, Visser WJ, Mees EJ, Njio L. Calcif Tissue Res; 1974; 16(2):129-38. PubMed ID: 4447892 [No Abstract] [Full Text] [Related]
7. Serum hydroxyproline and renal osteodystrophy in patients maintained on haemodialysis. Goulding A, McChesney R, Irvine RO, Dixon SR. N Z Med J; 1974 Dec 25; 80(530):540-4. PubMed ID: 4615274 [No Abstract] [Full Text] [Related]
13. A possible role for propranolol in the treatment of renal osteodystrophy. Caro JF, Besarab A, Burke JF, Glennon JA. Lancet; 1978 Aug 26; 2(8087):451-4. PubMed ID: 79809 [Abstract] [Full Text] [Related]
14. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)]. Pogglitsch H, Schmidberger H, Gell G. MMW Munch Med Wochenschr; 1976 Jan 30; 118(5):131-6. PubMed ID: 814443 [Abstract] [Full Text] [Related]
15. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy]. Di Landro D, Zanatta GP, Simioni N, Pinzani A, Zotti D, Perin N, Bertoli M, Naso A, Ruffatti A, Gasparotto ML. Minerva Med; 1985 Mar 10; 76(9-10):419-23. PubMed ID: 3982699 [No Abstract] [Full Text] [Related]
16. PTH and bone markers of renal osteodystrophy in predialysis chronic renal failure. Coen G, Mazzaferro S, Ballanti P, Bonucci E. J Endocrinol Invest; 1992 Mar 10; 15(9 Suppl 6):129-33. PubMed ID: 1300330 [No Abstract] [Full Text] [Related]
17. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease. Fournier AE, Bordier PJ, Gueris J, Chanard J, Marie P, Ferriere C, Osario M, Bedrossian J, De Luca HF. Calcif Tissue Res; 1976 Aug 10; 21 Suppl():226-35. PubMed ID: 782662 [No Abstract] [Full Text] [Related]
18. A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations. Meany DL, Jan de Beur SM, Bill MJ, Sokoll LJ. Clin Chem; 2009 Sep 10; 55(9):1737-9. PubMed ID: 19717659 [No Abstract] [Full Text] [Related]
19. Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study. Luo L, Chen Q. J Int Med Res; 2020 Feb 10; 48(2):300060519895844. PubMed ID: 32054360 [Abstract] [Full Text] [Related]
20. Parathyroid hormone, calcium and phosphate balance in hemofiltration. Fuchs C, Doht B, Dorn D, McIntosh C, Ritter D, Scheler F. J Dial; 1977 Feb 10; 1(6):631-40. PubMed ID: 608872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]